Maralixibat in progressive familial intrahepatic cholestasis (MARCH-PFIC): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.
Simon P Horslen, Wolf-Dietrich Huber, Susan Gilmour, Regino P Gonzalez-Peralta, Nagraj Kasi, Udeme Ekong, Gilda Porta, Thomas Jaecklin, Alexander G Miethke, Nadia Ovchinsky, Fang Kuan Chiou, Daniel D'Agostino, Lorenzo D'Antiga, Noemie Laverdure, Jane Hartley, Vera F Hupertz, Anamaria Lascau, Naveen Mittal, Amal A Aqul, Felipe Ordonez, Joshue Covarrubias Esquer, Nolwenn Laborde, Ulrich Baumann, Piotr Czubkowski, Etienne Sokal, Pamela Vig, Will Garner, Richard J Thompson, Robert H Squires, Cigdem Arikan, Douglas B Mogul, Antonella Mosca, Chuan-Hao Lin, Lara Longpre, Tiago Nunes, Adib Moukarzel
The lancet. Gastroenterology & hepatology 2024;9(7):620-631